Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices 64655 

ANNUAL BURDEN ESTIMATES—Continued 

Instrument Number of respondents 

Number of responses per 

respondent 

Average burden hours per 

response 

Total burden 

hours 

307.5(a) System, Certification ......................................................................... 2 1 240 480 

307.11(e)(1)(ii), Collection of Non-IV–D Data for SCR—States ..................... 54 25,200 .046 62,597 

Collection of Child Data for IV–D Cases for SCR—States ............................. 54 12,000 .083 53,784 

307.11(e)(1)(ii), Collection of Non-IV–D Data for SCR—Courts ..................... 3,045 447 .029 39,472 

307.11(e)(3)(v), Collection of Child Data for IV–D cases for SCR—Courts ... 3,045 213 .083 53,833 

307.11(f)(1), Case Data Transmitted from SCR to FCR—New cases and 

case updates ................................................................................................ 54 52 2.82 7,919 

Estimated Total Annual Burden 

Hours: 218,709. 

Additional Information: Copies of the 

proposed collection may be obtained by 

writing to the Administration for 

Children and Families; Office of 

Administration, Office of Information 

Services, 370 L’Enfant Promenade, SW., 

Washington DC 20447, Attn: ACF 

Reports Clearance Officer. All requests 

should be identified by the title of the 

information collection. E-mail address: 

infocollection@acf.hhs.gov. 

OMB Comment: OMB is required to 

make a decision concerning the 

collection of information between 30 

and 60 days after publication of this 

document in the Federal Register. 

Therefore, a comment is best assured of 

having its full effect if OMB receives it 

within 30 days of publication. Written 

comments and recommendations for the 

proposed information collection should 

be sent directly to the following: Office 

of Management and Budget, Paperwork 

Reduction Project, Fax: 202–395–6974, 

Attn: Desk Officer for the 

Administration for Children and 

Families. 

November 7, 2007. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 07–5652 Filed 11–15–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Initial Review Group; Subcommittee 

A—Cancer Centers. 

Date: December 6–7, 2007. 

Time: 8 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Gail J. Bryant, MD, 

Scientific Review Administrator, Grants 

Review Branch, Division of Extramural 

Activities, National Cancer Institute, National 

Institutes of Health, 6116 Executive 

Boulevard, Room 8042, Bethesda, MD 20852–

7405, (301) 402–0801. 

Name of Committee: National Cancer 

Institute Special Panel; Cancer Center 

Support Grant. 

Dated: December 6, 2007 

Time: 2:40 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Double Tree Bethesda, 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: David E. Maslow, PhD, 

Chief, Resources and Training Review 

Branch, Division of Extramural Activities, 

National Cancer Institute, National Institutes 

of Health, 6116 Executive Boulevard—Room 

8117, Bethesda, MD 20892–7405, (301) 496–

2330. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Prevention, 

Control and Population Sciences. 

Date: January 30–31, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Gaithersburg 

Washingtonian Center, 204 Boardwalk Place, 

Gaithersburg, MD 20878. 

Contact Person: Wlodek Lopaczynski, MD, 

PhD, Scientific Review Administrator, 

Research Programs Review Branch, Division 

of Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd. Room 8131, 

Bethesda, MD 20892, 301–594–1402, 

lopacw@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Molecular 

Oncology. 

Date: February 6–8, 2008. 

Time: 5:30 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Michael B. Small, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8127, Bethesda, MD 

20892–8328, 301–402–0996, 

smallm@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SPORE in 

Lymphoma, Myeloma, Pancreas, GI, H&N 

and Lung Cancers. 

Date: February 12–14, 2008. 

Time: February 12, 2008, 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda, 5151 Pooks Hill 

Rd., Bethesda, MD 20814. 

Contact Person: Shamala K. Srinivas, PhD, 

Scientific Review Administrator, Research 

Programs Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Boulevard, Room 8123, Bethesda, 

MD 20892, 301–594–1224, ss537t@nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; SPORE in 

Breast, Gynecologic, Genitourinary and 

Prostate Cancers. 

Date: February 12–14, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Caron Lyman, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Cancer 

Institute, National Institutes of Health, 6116 

Executive Blvd., Room 8119, Bethesda, MD 

20892–8328, 301–451–4761, 

lymanc@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; 

Application of Emerging Technologies for 

Cancer Research. 

Date: March 19–20, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Marvin L. Salin, PhD, 

Scientific Review Administrator, Special 

mstockstill on PROD1PC66 with NOTICES

64656 Federal Register / Vol. 72, No. 221 / Friday, November 16, 2007 / Notices 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

7073, Bethesda, MD 20892–8329, 301–496–

0694, msalin@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower, 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: November 7, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5677 Filed 11–15–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Alternative Medicine; Notice of Meeting 

Pursuant to Section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the National Advisory 

Council for Complementary and 

Alternative Medicine (NACCAM) 

meeting. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applicants and/ 

or contract proposals and the discussion 

could disclose confidential trade secrets 

or commercial property such as 

patentable material, and personal 

information concerning individuals 

associated with the grant applications 

and/or contract proposals, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Advisory 

Council for Complementary and Alternative 

Medicine. 

Date: February 1, 2008. 

Closed: 8 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Open: 1 p.m. to 4:30 p.m. 

Agenda: Opening remarks by the Acting 

Director of National Center for 

Complementary and Alternative Medicine, 

presentation of a new research initiative, and 

other business of the Council. 

Place: National Institutes of Health, 

Neuroscience Building, 6001 Executive 

Boulevard, Conference Rooms C & D, 

Bethesda, MD 20892. 

Contact Person: Martin H. Goldrosen, PhD, 

Executive Secretary, National Center for 

Complementary, and Alternative Medicine, 

National Institutes of Health, 6707 

Democracy Blvd., Suite 401, Bethesda, MD 

20892, (301) 594–2014. 

The public comments session is scheduled 

from 4–4:30 p.m., but could change 

depending on the actual time spent on each 

agenda item. Each speaker wil be permitted 

5 minutes for their presentation. Interested 

individuals and representatives of 

organizations are requested to notify Dr. 

Martin H. Goldrosen, National Center for 

Complementary and Alternative Medicine, 

NIH, 6707 Democracy Boulevard, Suite 401, 

Bethesda, Maryland 20892, 301–594–2014, 

Fax: 301–480–9970. Letters of intent to 

present comments, along with a brief 

description of the organization represented, 

should be received no later than 5 p.m. on 

January 30, 2008. Only one representative of 

an organization may present oral comments. 

Any person attending the meeting who does 

not request an opportunity to speak in 

advance of the meeting may be considered 

for oral presentation, if time permits, and at 

the discretion of the Chairperson. In 

addition, written comments may be 

submitted to Dr. Martin H. Goldrosen at the 

address listed above up to ten calendar days 

(February 11, 2008) following the meeting. 

Copies of the meeting agenda and the 

roster of members will be furnished upon 

request by contacting Dr. Martin H. 

Goldrosen, Executive Secretary, NACCAM, 

National Center for Complementary and 

Alternative Medicine, National Institutes of 

Health, 6707 Democracy Boulevard, Suite 

401, Bethesda, Maryland 20892, 301–594–

2014, Fax 301–480–9970, or via e-mail at 

naccames@mail.nih.gov. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by nongovernment 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building. 

Dated: November 7, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5665 Filed 11–15–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; Pathways to 

Independence K99/R00 Applications. 

Date: November 27, 2007. 

Time: 1 p.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Eye Institute, 5635 Fishers 

Lane, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Anne E. Schaffner, PhD, 

Scientific Review Administrator, Division of 

Extramural Research, National Eye Institute, 

5635 Fishers Lane, Suite 1300, MSC 9300, 

Bethesda, MD 20892–9300, (301) 451–2020, 

aes@nei.nih.gov. 

Name of Committee: National Eye Institute 

Special Emphasis Panel; Pathways to 

Independence Applications II. 

Date: November 28, 2007. 

Time: 12 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Eye Institute, 5635 Fishers 

Lane, Bethesda, MD 20892 (Telephone 

Conference Call). 

Contact Person: Anne E. Schaffner, PhD, 

Scientific Review Administrator, Division of 

Extramural Research, National Eye Institute, 

5635 Fishers Lane, Suite 1300, MSC 9300, 

Bethesda, MD 20892–9300, (301) 451–2020, 

aes@nei.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: November 6, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–5664 Filed 11–15–07; 8:45 am] 

BILLING CODE 4140–01–M 

mstockstill on PROD1PC66 with NOTICES